U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Developing novel immunotherapy strategies for HPV-associated respiratory papillomatosis

Author(s):
Allen, Clint, speaker
National Institutes of Health (US), issuing body
Title(s):
Developing novel immunotherapy strategies for HPV-associated respiratory papillomatosis / Clint Allen.
Series:
NIH director's seminar
Country of Publication:
United States
Publisher:
[Bethesda, Md.] : [National Institutes of Health], [2023]
Description:
1 online resource (1 streaming video file (1 hr., 1 min.)) : color, sound.
Language:
English
Electronic Links:
https://videocast.nih.gov/watch=49341
Summary:
(CIT): Recurrent respiratory papillomatosis (RRP) is a rare disorder that manifests as progressively growing aerodigestive tract papillomas that cause profound voice disturbance and airway obstruction. The disorder is caused by chronic infection with HPV type 6 or 11. One research interest of the Allen lab is to develop and study novel, rationally designed therapeutic approaches for RRP. In this lecture, Dr. Allen will highlight newly identified mechanisms of immune escape utilized by HPV6 or 11 to escape innate and adaptive immunity and discuss the results of prospective immunotherapy clinical trials conducted at the NIH Clinical Center for this disease.
MeSH:
Human papillomavirus 31/pathogenicity
Immunotherapy
Papilloma/immunology*
Papilloma/therapy
Respiratory Tract Neoplasms/immunology*
Publication Type(s):
Lecture
Webcast
Notes:
Recorded March 17, 2023.
Closed-captioned.
Terms of Use:
Access restricted to HHS only.
Other ID:
(DNLM)33041
(OCoLC)1416046003
NLM ID:
9918592672606676 [Remote electronic resource, Videorecording]

Supplemental Content

Loading ...